Further molecular docking simulation was performed to elucidate the specific target protein in podocytopathy that Forsythiaside worked to intervene for the amelioration of DKD, and we found that Forsythiaside could play a key role in the treatment of DKD podocytopathy by targeting RHOA and PRKCA protein. Here, PRKCA is linked to diabetic kidney disease.